An update on laboratory measurements of Dabigatran: Smart specific and calibrated dedicated assays for measuring anti-IIa activity in plasma.

Amiral, Jean; Dunois, Claire; Amiral, Cédric; Seghatchian, Jerard

Amiral, Jean; Dunois, Claire; Amiral, Cédric; Seghatchian, Jerard.

Afiliação

Amiral J; Hyphen BioMed, Neuville sur Oise, Paris, France. Electronic address: jamiral@hyphen-biomed.com.
Dunois C; Hyphen BioMed, Neuville sur Oise, Paris, France.
Amiral C; Research and Development, Hyphen BioMed, Neuville sur Oise, Paris, France.
Seghatchian J; International Consultancy in Blood Components Quality/Safety Improvement, Audit/Inspection and DDR Strategies, London, UK. Electronic address: jseghatchian@btopenworld.com.

Transfus Apher Sci ; 54(3): 428-37, 2016 Jun.

Article em En | MEDLINE | ID: mdl-27216543

Assuntos

Anticoagulantes/farmacocinética; Dabigatrana/farmacocinética; Administração Oral; Anticoagulantes/uso terapêutico; Dabigatrana/uso terapêutico; Humanos

Palavras-chave

Bleeding risk; Chromogenic anti-IIa assay; Dabigatran; Diluted thrombin time; Patient management

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dabigatrana / Anticoagulantes Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google